APOL1-mediated cell injury involves disruption of conserved trafficking processes

Journal of the American Society of Nephrology

Volumn 28, Issue 4, 2017, Pages 1117-1130

  Kruzel Davila, Etty ^a   Shemer, Revital ^b   Ofir, Ayala ^a   Bavli Kertselli, Ira ^a   Darlyuk Saadon, Ilona ^b   Oren Giladi, Pazit ^a   Wasser, Walter G ^a,c   Magen, Daniella ^a,b   Zaknoun, Eid ^b   Schuldiner, Maya ^d   Salzberg, Adi ^b   Kornitzer, Daniel ^b   Marelja, Zvonimir ^e   Simons, Matias ^e   Skorecki, Karl ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Mayanei Hayeshua Medical Center   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e IMAGINE INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RED FLUORESCENT PROTEIN; APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN;

APOL1 G0 GENE; APOL1 G1 GENE; APOL1 G2 GENE; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CELL DAMAGE; CONFERENCE PAPER; CYTOTOXICITY; DROSOPHILA MELANOGASTER; GENE EXPRESSION; GENE PRODUCT; GENETIC VARIABILITY; KIDNEY DISEASE; LETHALITY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; ALLELE; ANIMAL; CELL DEATH; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PH; PHYSIOLOGY; PROTEIN TRANSPORT;

ALLELES; ANIMALS; APOLIPOPROTEINS; CELL DEATH; DROSOPHILA MELANOGASTER; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOPROTEINS, HDL; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE;

EID: 85021848570     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016050546     Document Type: Conference Paper

References (84)

1. GenoveseG, FriedmanDJ, RossMD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
2. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, BradmanN, WasserWG, BeharDM, Skorecki K: Missensemutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to theMYH9 gene. HumGenet 128: 345-350, 2010
3. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, SmithMC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
4. Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH: APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 24: 1484-1491, 2013
5. Parsa A, KaoWH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr., Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, JensvoldNG, Tao K, LipkowitzMS, Appel LJ; AASK Study Investigators; CRIC Study Investigators: APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369: 2183-2196, 2013
6. Kruzel-Davila E, Wasser WG, Aviram S, Skorecki K: APOL1 nephropathy: From gene to mechanisms of kidney injury. Nephrol Dial Transplant 31: 349-358, 2016
7. Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, Limou S, Sezgin E, NelsonGW, FogoAB, Goetsch S, Kopp JB, WinklerCA, Naicker S: APOL1 risk variants are strongly associated with HIV-associated nephropathy inblack SouthAfricans. JAmSocNephrol 26: 2882-2890, 2015
8. Page NM, Butlin DJ, Lomthaisong K, Lowry PJ: The human apolipoprotein L gene cluster: Identification, classification, and sites of distribution. Genomics 74: 71-78, 2001
9. Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ: The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79: 539-546, 2002
10. Smith EE, Malik HS: The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res 19: 850-858, 2009
11. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E: Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422: 83-87, 2003
12. Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homblé F, Vanhamme L, Tebabi P, Pays A, Poelvoorde P, Jacquet A, Brasseur R, Pays E: Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309: 469-472, 2005
13. Thomson R, Genovese G, Canon C, Kovacsics D, Higgins MK, CarringtonM, Winkler CA, Kopp J, Rotimi C, Adeyemo A, Doumatey A, Ayodo G, Alper SL, Pollak MR, Friedman DJ, Raper J: Evolution of the primate trypanolytic factor APOL1. Proc Natl Acad Sci USA 111: E2130-E2139, 2014
14. Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, Imus PH, Mhatre AN, Lawani AK, Julian BA, Wyatt RJ, Novak J, Wyatt CM, RossMJ, Winston JA, Klotman ME, Cohen DJ, Appel GB, D'Agati VD, Klotman PE, Gharavi AG: APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 22: 1991-1996, 2011
15. Kanji Z, Powe CE, Wenger JB, Huang C, Ankers E, Sullivan DA, Collerone G, Powe NR, Tonelli M, Bhan I, Bernhardy AJ, Dibartolo S, Friedman D, Genovese G, Pollak MR, Thadhani R: Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 22: 2091-2097, 2011
16. Tzur S, Rosset S, Skorecki K, Wasser WG: APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic endstage kidney disease. Nephrol Dial Transplant 27: 1498-1505, 2012
17. Divers J, Núñez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI: JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int 84: 1207-1213, 2013
18. Freedman BI, Skorecki K: Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. Clin J AmSoc Nephrol 9: 2006-2013, 2014
19. NicholsB, Jog P, Lee JH, BlacklerD, Wilmot M, D'AgatiV, MarkowitzG, Kopp JB, Alper SL, PollakMR, Friedman DJ: Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int 87: 332-342, 2015
20. Capewell P, Cooper A, Clucas C, Weir W, Macleod A: A co-evolutionary arms race: Trypanosomes shaping the human genome, humans shaping the trypanosome genome. Parasitology 142[Suppl 1]: S108-S119, 2015
21. Johnstone DB, Shegokar V, Nihalani D, Rathore YS, Mallik L, Ashish, Zare V, Ikizler HO, Powar R, Holzman LB: APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS One 7: E51546, 2012
22. Lan X, Jhaveri A, Cheng K, Wen H, SaleemMA, Mathieson PW, Mikulak J, Aviram S, Malhotra A, Skorecki K, Singhal PC: APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol 307: F326-F336, 2014
23. Lan X, Wen H, Lederman R, Malhotra A, Mikulak J, PopikW, Skorecki K, Singhal PC: Protein domains of APOL1 and its risk variants. Exp Mol Pathol 99: 139-144, 2015
24. Lan X, Wen H, Saleem MA, Mikulak J, Malhotra A, Skorecki K, Singhal PC: Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu. Exp Mol Pathol 98: 491-501, 2015
25. Cheng D, Weckerle A, Yu Y, Ma L, Zhu X, Murea M, Freedman BI, Parks JS, Shelness GS: Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. J Lipid Res 56: 1583-1593, 2015
26. Khatua AK, CheathamAM, Kruzel ED, Singhal PC, Skorecki K, PopikW: Exon 4 encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1. Am J Physiol Cell Physiol 309: C22-C37, 2015
27. Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S III, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR: APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci USA 113: 830-837, 2015
28. Olabisi O, Al-Romaih K, Henderson J, Tomar R, Drummond I, MacRae C, Pollak M: From man to fish: What can Zebrafish tell us about ApoL1 nephropathy? [published online ahead of print August 10, 2016]. Clin Nephrol doi: 10.5414/CNP86S116
29. Heneghan JF, VandorpeDH, ShmuklerBE, Giovinazzo JA, Raper J, Friedman DJ, PollakMR, AlperSL:BH3domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins. Am J Physiol Cell Physiol 309: C332-C347, 2015
30. Limou S, Dummer PD, Nelson GW, Kopp JB, Winkler CA: APOL1 toxin, innate immunity, and kidney injury. Kidney Int 88: 28-34, 2015
31. Raper J, Nussenzweig V, Tomlinson S: The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J ExpMed 183: 1023-1029, 1996
32. Weckerle A, Snipes JA, Cheng D, Gebre AK, Reisz JA, Murea M, Shelness GS, Hawkins GA, Furdui CM, Freedman BI, Parks JS, Ma L: Characterization of circulating APOL1 protein complexes in African Americans. J Lipid Res 57: 120-130, 2015
33. Vanhollebeke B, Pays E: The trypanolytic factor of human serum:Manyways to enter the parasite, a single way to kill. Mol Microbiol 76: 806-814, 2010
34. Hu CA, Klopfer EI, Ray PE: Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Lett 586: 947-955, 2012
35. Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR: APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 22: 2119-2128, 2011
36. Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, Saleem MA, Satchell SC, Banas B, Mathieson PW, Kretzler M, Hemal AK, Rudel LL, Petrovic S, Weckerle A, Pollak MR, Ross MD, Parks JS, Freedman BI: Localization of APOL1 protein and mRNA in the human kidney:Nondiseased tissue, primary cells, and immortalized cell lines. J Am Soc Nephrol 26: 339-348, 2015
37. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, GautreauxMD, Divers J, Freedman BI: The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11: 1025-1030, 2011
38. Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A: The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant 12: 1924-1928, 2012
39. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J: Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. AmJ Transplant 15: 1615-1622, 2015
40. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J: APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Transplantation 100: 194-202, 2016
41. Molina-Portela MP, Samanovic M, Raper J: Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J ExpMed 205: 1721-1728, 2008
42. Lecordier L, Vanhollebeke B, Poelvoorde P, Tebabi P, Paturiaux-Hanocq F, Andris F, Lins L, Pays E: C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosomabrucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog 5: E1000685, 2009
43. Weavers H, Prieto-Sánchez S, Grawe F, Garcia-López A, Artero R, Wilsch-Bräuninger M, Ruiz-Gómez M, Skaer H, Denholm B: The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature 457: 322-326, 2009
44. Zhang F, Zhao Y, Han Z: An in vivo functional analysis system for renal gene discovery in Drosophila pericardial nephrocytes. J Am Soc Nephrol 24: 191-197, 2013
45. Zhuang S, Shao H, Guo F, Trimble R, Pearce E, Abmayr SM: Sns and Kirre, theDrosophila orthologs ofNephrin andNeph1, direct adhesion, fusion and formation of a slit diaphragm-like structure in insect nephrocytes. Development 136: 2335-2344, 2009
46. Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, Depalma SR, GuptaN, Gabriel SB, Taylor HA Jr., Fox ER, Newton-Cheh C, Kathiresan S, Hirschhorn JN, Altshuler DM, Pollak MR, Wilson JG, Seidman JG, Seidman C: Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res 114: 845-850, 2014
47. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA: Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem 283: 21540-21549, 2008
48. Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstädt H, Kerjaschki D, Mizushima N, Shaw AS, Walz G, Huber TB: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096, 2010
49. Chen J, Chen MX, Fogo AB, Harris RC, Chen JK: MVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J AmSoc Nephrol 24: 198-207, 2013
50. Bechtel W, Helmstädter M, Balica J, Hartleben B, Kiefer B, Hrnjic F, Schell C, KretzO, Liu S, Geist F, Kerjaschki D, Walz G, Huber TB: Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol 24: 727-743, 2013
51. Akilesh S, Huber TB, Wu H, Wang G, Hartleben B, Kopp JB, Miner JH, Roopenian DC, Unanue ER, Shaw AS: Podocytes use FcRn to clear IgG fromthe glomerular basementmembrane. Proc NatlAcad SciUSA 105: 967-972, 2008
52. Soda K, Ishibe S: The function of endocytosis in podocytes. Curr Opin Nephrol Hypertens 22: 432-438, 2013
53. Sampogna RV, Al-Awqati Q: Taking a bite: Endocytosis in the maintenance of the slit diaphragm. J Clin Invest 122: 4330-4333, 2012
54. Soda K, Balkin DM, Ferguson SM, Paradise S, Milosevic I, Giovedi S, Volpicelli-Daley L, Tian X, Wu Y, Ma H, Son SH, Zheng R, Moeckel G, Cremona O, Holzman LB, De Camilli P, Ishibe S: Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest 122: 4401-4411, 2012
55. Backer JM: The regulation and function ofClass III PI3Ks:Novel roles for Vps34. Biochem J 410: 1-17, 2008
56. Kihara A, Noda T, Ishihara N, Ohsumi Y: Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidaseY sortingin Saccharomyces cerevisiae. JCell Biol 152: 519-530, 2001
57. Kim J, KimYC, FangC, Russell RC, KimJH, FanW, Liu R, ZhongQ, Guan KL: Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152: 290-303, 2013
58. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y: Dynamics and diversity in autophagy mechanisms: Lessons from yeast. Nat Rev Mol Cell Biol 10: 458-467, 2009
59. Obara K, Sekito T, Ohsumi Y: Assortment of phosphatidylinositol 3-kinase complexes-Atg14p directs association of complex I to the preautophagosomal structure in Saccharomyces cerevisiae. Mol Biol Cell 17: 1527-1539, 2006
60. Katzmann DJ, Babst M, Emr SD: Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106: 145-155, 2001
61. Eskelinen EL, Tanaka Y, Saftig P: At the acidic edge: Emerging functions for lysosomal membrane proteins. Trends Cell Biol 13: 137-145, 2003
62. Corbacho I, Teixidó F, Olivero I, Hernández LM: Dependence of Saccharomyces cerevisiae Golgi functions on V-ATPase activity. FEMS Yeast Res 12: 341-350, 2012
63. Smardon AM, Diab HI, TarsioM, Diakov TT, Nasab ND, West RW, Kane PM: The RAVE complex is an isoform-specific V-ATPase assembly factor in yeast. Mol Biol Cell 25: 356-367, 2014
64. Kane PM: The where, when, and how of organelle acidification by the yeast vacuolar H+-ATPase. Microbiol Mol Biol Rev 70: 177-191, 2006
65. Huotari J, Helenius A: Endosome maturation. EMBO J 30: 3481-3500, 2011
66. Ko CH, Gaber RF: TRK1 and TRK2 encode structurally related K+ transporters in Saccharomyces cerevisiae. Mol Cell Biol 11: 4266-4273, 1991
67. Toshima JY, Nishinoaki S, Sato Y, YamamotoW, Furukawa D, Siekhaus DE, Sawaguchi A, Toshima J: Bifurcation of the endocytic pathway into Rab5-dependent and -independent transport to the vacuole. Nat Commun 5: 3498, 2014
68. Genovese G, Friedman DJ, Pollak MR: APOL1 variants and kidney disease in people of recent African ancestry. Nat Rev Nephrol 9: 240-244, 2013
69. Kim HJ, Zhong Q, Sheng ZH, Yoshimori T, Liang C, Jung JU: Beclin-1-interacting autophagy protein Atg14L targets the SNARE-associated protein Snapin to coordinate endocytic trafficking. JCell Sci 125: 4740-4750, 2012
70. Liang C, Lee JS, Inn KS, GackMU, LiQ, Roberts EA, Vergne I, Deretic V, Feng P, Akazawa C, Jung JU: Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 10: 776-787, 2008
71. Sharma AK, Friedman DJ, Pollak MR, Alper SL: Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney diseaseassociated mutants of apolipoprotein L1. FEBS J 283: 1846-1862, 2016
72. Vanwalleghem G, Fontaine F, Lecordier L, Tebabi P, Klewe K, Nolan DP, Yamaryo-Botté Y, Botté C, Kremer A, Burkard GS, Rassow J, Roditi I, Pérez-Morga D, Pays E: Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1. Nat Commun 6: 8078, 2015
73. Thomson R, Finkelstein A: Human trypanolytic factor APOL1 forms pHgated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis. Proc Natl Acad Sci USA 112: 2894-2899, 2015
74. Stutz A, Golenbock DT, Latz E: Inflammasomes: Too big to miss. J Clin Invest 119: 3502-3511, 2009
75. Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, Kopp JB: APOL1 kidney disease risk variants: An evolving landscape. Semin Nephrol 35: 222-236, 2015
76. Taylor HE, Khatua AK, Popik W: The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol 88: 592-603, 2014
77. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Côté M, Rich RL, Myszka DG, Sundquist WI: Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65, 2001
78. Martin-Serrano J, Zang T, Bieniasz PD: HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 7: 1313-1319, 2001
79. Zhang F, Zhao Y, Chao Y, Muir K, Han Z: Cubilin and amnionless mediate protein reabsorption in Drosophila nephrocytes. J Am Soc Nephrol 24: 209-216, 2013
80. St Pierre SE, Ponting L, Stefancsik R, McQuilton P; FlyBase Consortium: FlyBase 102-advanced approaches to interrogating FlyBase. Nucleic Acids Res 42: D780-D788, 2014
81. Bischof J, Maeda RK, Hediger M, Karch F, Basler K: An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci USA 104: 3312-3317, 2007
82. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, LongairM, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A: Fiji: An open-source platform for biological-image analysis. Nat Methods 9: 676-682, 2012
83. Musselman LP, Fink JL, Narzinski K, Ramachandran PV, Hathiramani SS, Cagan RL, Baranski TJ: A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila. Dis Model Mech 4: 842-849, 2011
84. Spokoini R, Moldavski O, Nahmias Y, England JL, Schuldiner M, Kaganovich D: Confinement to organelle-associated inclusion structures mediates asymmetric inheritance of aggregated protein in budding yeast. Cell Rep 2: 738-747, 2012